These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Role of activation-induced cytidine deaminase in inflammation-associated cancer development. Marusawa H; Takai A; Chiba T Adv Immunol; 2011; 111():109-41. PubMed ID: 21970953 [TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. Mas-Ponte D; Supek F Nat Genet; 2020 Sep; 52(9):958-968. PubMed ID: 32747826 [TBL] [Abstract][Full Text] [Related]
13. Transcription-coupled mutagenesis by the DNA deaminase AID. Larson ED; Maizels N Genome Biol; 2004; 5(3):211. PubMed ID: 15003109 [TBL] [Abstract][Full Text] [Related]
14. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849 [TBL] [Abstract][Full Text] [Related]
15. Genomics: the breast cancer landscape. Gray J; Druker B Nature; 2012 Jun; 486(7403):328-9. PubMed ID: 22722187 [No Abstract] [Full Text] [Related]